Oxytocin

Oxytocin is a cyclic nonapeptide that exerts its molecular effects primarily through the oxytocin receptor (OXTR), a G protein-coupled receptor (GPCR). The peptide's cyclic structure is maintained by a disulfide bond between cysteine residues at positions 1 and 6, while the C-terminal region contributes to receptor recognition and activation. [1]

Oxytocin–OXTR Binding

Oxytocin research provides a defined model for studying peptide–GPCR interactions. Oxytocin binds to OXTR within the receptor's transmembrane binding pocket, where interactions between the peptide and specific receptor residues help stabilize an active receptor conformation. [2] Structural studies using cryo-electron microscopy have provided detailed information about the oxytocin–OXTR complex, including conformational changes associated with ligand binding and receptor activation.[1]

G-Protein Coupling

Following oxytocin binding, OXTR can interact with heterotrimeric G proteins to initiate intracellular signaling. Research has primarily characterized coupling to the Gq/11 family, which connects receptor activation to downstream phospholipase C (PLC) signaling. [3] Studies of OXTR signaling have also investigated coupling to additional G-protein pathways, highlighting the potential for signaling responses to vary according to cellular context and receptor environment.

PLC and Calcium Signaling

Activation of OXTR-associated Gq/11 signaling can stimulate phospholipase C, leading to the generation of intracellular second messengers and subsequent changes in cytosolic calcium concentrations. Oxytocin has therefore been widely used in experimental systems investigating GPCR-mediated calcium signaling, including the relationship between receptor activation and intracellular calcium dynamics. [4]

MAPK and Downstream Signaling

OXTR activation can also engage downstream signaling pathways involving mitogen-activated protein kinases (MAPKs), including ERK1/2. Research examining these pathways provides a model for studying how activation of a peptide-responsive GPCR can produce signaling responses extending beyond the initial G-protein interaction. [5]

Oxytocin and Related Receptor Systems

Oxytocin is structurally related to vasopressin, and oxytocin and vasopressin receptors belong to the same broader family of class A GPCRs. Their structural similarities make the oxytocin–OXTR system useful for comparative studies of peptide recognition, receptor selectivity, ligand binding, and GPCR activation. Experimental research can therefore use oxytocin alongside related peptides to investigate how relatively small differences in peptide and receptor structure influence signaling behavior.

Overall, oxytocin provides a well-characterized research model for studying peptide–GPCR recognition, receptor activation, G-protein coupling, calcium signaling, MAPK pathways, and receptor selectivity. The specific signaling response can depend on receptor expression, cell type, ligand concentration, and experimental conditions.

Oxytocin Research Applications

Oxytocin is a well-characterized peptide ligand for OXTR, making it useful across several areas of molecular and cellular research. Experimental applications include:

OXTR Receptor Pharmacology

Oxytocin is used as a defined ligand for investigating the pharmacology of the oxytocin receptor (OXTR). Research has examined ligand binding, receptor activation, conformational changes, and the structural features that determine oxytocin recognition by OXTR. These studies provide a model for investigating peptide–GPCR interactions and receptor selectivity. [5][6]

Ligand–Receptor Interaction Studies

Structural studies have examined the molecular interactions between oxytocin and OXTR at the receptor binding site. Cryo-EM research has identified interactions between the peptide and receptor residues and characterized conformational changes associated with receptor activation. This work provides a structural framework for studying how peptide ligands translate binding interactions into GPCR activation. [1]

G-Protein Signaling Research

Oxytocin is used to investigate how OXTR activation engages heterotrimeric G proteins and initiates intracellular signaling. Experimental studies have characterized OXTR coupling to Gq/11 and examined how receptor activation influences downstream signaling pathways. These models can be used to study the relationship between receptor conformation, G-protein coupling, and cellular signaling. [8]

Calcium Signaling

OXTR-mediated signaling provides an experimental system for studying receptor-dependent changes in intracellular calcium. Research has examined the connection between OXTR activation, phospholipase C signaling, and calcium mobilization in receptor-expressing cellular models. Oxytocin can therefore serve as a defined ligand for investigating GPCR-regulated calcium dynamics. [4]

MAPK Signaling

Oxytocin and OXTR have also been investigated in relation to downstream mitogen-activated protein kinase (MAPK) pathways, including ERK1/2. These studies examine how activation of a peptide-responsive GPCR can engage signaling pathways beyond the initial receptor–G-protein interaction, providing a model for investigating intracellular signal transduction. [5]

Oxytocin–Vasopressin Receptor Comparisons

Because oxytocin and vasopressin are closely related nonapeptides and their receptors belong to the same GPCR family, oxytocin is useful in comparative receptor research. Studies can examine differences in ligand recognition, receptor selectivity, receptor activation, and downstream signaling between oxytocin receptors and vasopressin receptor subtypes. These comparisons help researchers investigate how closely related peptide ligands and receptors produce distinct molecular responses. [9]

Overall, oxytocin provides a defined research model for investigating OXTR pharmacology, peptide–GPCR interactions, G-protein coupling, calcium signaling, MAPK pathways, and receptor selectivity in controlled experimental systems.

Oxytocin vs Kisspeptin-10 vs Melanotan II Comparison

Oxytocin can be compared with other peptide research materials to examine how differences in peptide structure, receptor family, and signaling mechanism influence experimental outcomes. Kisspeptin-10 provides a useful comparison because it is also a defined peptide ligand for a class A GPCR, while Melanotan II provides a contrasting model of a cyclic peptide that acts primarily through the melanocortin receptor family.

Note: All materials listed for laboratory research use only

Although all three compounds can be used to investigate peptide–GPCR signaling, they represent different receptor systems and should not be treated as interchangeable research tools. Oxytocin is centered on OXTR pharmacology, Kisspeptin-10 on KISS1R signaling, and Melanotan II on melanocortin receptor activity.

These differences make the compounds useful for comparative studies of receptor recognition, ligand selectivity, G-protein coupling, and downstream signal transduction.

Other Related Peptides for Comparative Research

Melanotan I (afamelanotide) provides another useful comparison for researchers studying peptide receptor pharmacology. It is a modified α-MSH analogue investigated primarily in relation to MC1R and melanocortin-system signaling. Unlike oxytocin, which provides a model for OXTR signaling, Melanotan I is useful for examining melanocortin receptor activation and associated cellular pathways.

PT-141 (bremelanotide) is another melanocortin-system signaling peptide. It is structurally related to the melanotan family but is studied primarily in the context of melanocortin receptor pharmacology, particularly MC4R-associated signaling. Comparing PT-141 with oxytocin therefore allows researchers to examine two structurally distinct peptide ligands acting on different GPCR systems.

These compounds can be useful as comparative receptor-pharmacology tools, but findings from one peptide or receptor system should not automatically be extrapolated to another. Experimental results depend on factors including receptor subtype, ligand structure, cell type, receptor expression, and assay conditions.

Storage & Laboratory Handling

Oxytocin is supplied as a lyophilized research peptide. Proper storage and laboratory handling can help maintain sample integrity and preserve the material's analytical characteristics.

• Keep the vial tightly sealed when not being handled.

• Store at the temperature specified by the manufacturer and appropriate for the intended storage period.

• Protect the material from excessive heat, light, and moisture.

• Minimize exposure to ambient humidity during handling.

• Avoid unnecessary temperature fluctuations and repeated freeze-thaw cycles.

• When transferring a refrigerated or frozen vial between environments, keep the container sealed while it equilibrates to help minimize condensation.

• Use clean laboratory handling practices appropriate for peptide research materials.

• Maintain the original product label and batch/lot information for traceability.

• Retain the applicable Certificate of Analysis (COA) with the batch documentation.

• Follow laboratory-specific standard operating procedures and applicable institutional requirements.

Peptide stability can vary according to factors such as formulation, storage conditions, handling, and the specific production batch. Researchers should therefore avoid assuming a universal shelf life or stability profile and should refer to the manufacturer's current storage guidance, product documentation, and validated laboratory procedures for the specific oxytocin material being studied.

Third-Party Testing & COA

When you buy oxytocin peptide from Bluum Peptides, you can review batch-specific analytical documentation for the research material you receive. Each new batch is independently tested by third-party laboratories for applicable parameters including identity, purity, sterility, and endotoxins, with the results documented in a Certificate of Analysis (COA).

You can also use the Bluum Peptides COA Lookup page to access available certificates and review the analytical results associated with individual production lots. The documentation can also identify the independent laboratory responsible for the testing, providing additional traceability for the reported results.

Because analytical results can vary between production lots, you should refer to the current batch-specific COA for the exact purity, identity, endotoxin results, and other applicable quality-control data for the material you receive.

Frequently Asked Questions About Oxytocin

What is oxytocin peptide?

Oxytocin is a synthetic cyclic nonapeptide consisting of nine amino acids. Its structure contains a disulfide bond between cysteine residues at positions 1 and 6, creating the characteristic cyclic portion of the molecule. Oxytocin is primarily studied as a ligand for the oxytocin receptor (OXTR), a class A G protein-coupled receptor (GPCR).

What is oxytocin peptide used for in research?

Oxytocin is used as a research material for investigating peptide–receptor interactions and OXTR signaling. Experimental studies have examined ligand binding, receptor activation, G-protein coupling, intracellular calcium signaling, phospholipase C pathways, and downstream MAPK signaling. It can also be used in comparative studies examining the structural and pharmacological relationships between oxytocin and related peptides such as vasopressin.

How does oxytocin interact with the oxytocin receptor (OXTR)?

Oxytocin binds to the oxytocin receptor (OXTR), a class A GPCR, within a defined ligand-binding pocket formed by the receptor's transmembrane domains. Structural studies have identified interactions between oxytocin and specific receptor residues and have characterized conformational changes associated with receptor activation. These findings provide a molecular framework for investigating how peptide binding translates into GPCR signaling.

What signaling pathways does oxytocin activate?

Oxytocin activates OXTR-associated intracellular signaling pathways that have been characterized primarily through Gq/11 coupling. This can engage phospholipase C and downstream calcium signaling, while experimental studies have also investigated OXTR-associated ERK1/2 and other MAPK pathways. Additional G-protein coupling has been reported, indicating that the signaling response can vary according to the receptor environment and experimental model.

How is oxytocin different from vasopressin?

Oxytocin and vasopressin are closely related cyclic nonapeptides with similar overall structures, but they differ in their amino acid sequences and receptor selectivity. Oxytocin is primarily investigated through the oxytocin receptor (OXTR), while vasopressin can interact with several receptor subtypes, including V1a, V1b, and V2. Comparing the two peptides provides a useful model for studying how small structural differences influence peptide–GPCR recognition and signaling.

How is oxytocin tested for purity and identity?

Oxytocin can be characterized using analytical techniques including high-performance liquid chromatography (HPLC) and mass spectrometry (MS). HPLC can provide information about chromatographic purity, while mass spectrometry can help confirm molecular identity and mass characteristics. If you buy oxytocin peptide from Bluum Peptides, you can review the batch-specific Certificate of Analysis (COA) for the applicable analytical results associated with the material you receive.

Where can I buy oxytocin peptide for laboratory research?

You can buy oxytocin peptide from Bluum Peptides as a 5 mg lyophilized research peptide supplied in a sealed 3 mL vial. Bluum Peptides maintains strict purity and quality standards, typically over 99%. Check the provided batch-specific Certificate of Analysis for exact quality parameters such as identity, purity, and sterility. Oxytocin is sold strictly for laboratory research use and is not intended for human or veterinary use.

Scientific References

1. Meyerowitz JG, Robertson MJ, Barros-Álvarez X, Panova O, Nwokonko RM, Gao Y, Skiniotis G. The oxytocin signaling complex reveals a molecular switch for cation dependence. Nat Struct Mol Biol. 2022 Mar;29(3):274-281.
   doi: 10.1038/s41594-022-00728-4. Epub 2022 Mar 3. PMID: 35241813; PMCID: PMC12101619.

2. Borroto-Escuela DO, Cuesta-Marti C, Lopez-Salas A, Chruścicka-Smaga B, Crespo-Ramírez M, Tesoro-Cruz E, Palacios-Lagunas DA, Perez de la Mora M, Schellekens H, Fuxe K. The oxytocin receptor represents a key hub in the GPCR heteroreceptor network: potential relevance for brain and behavior. Front Mol Neurosci. 2022 Dec 8;15:1055344.
   doi: 10.3389/fnmol.2022.1055344. PMID: 36618821; PMCID: PMC9812438.

3. Jurek B, Neumann ID. The Oxytocin Receptor: From Intracellular Signaling to Behavior. Physiol Rev. 2018;98:1805-1908.
   doi: 10.1152/physrev.00031.2017.

4. Gárriz A, Aubry S, Wattiaux Q, Bair J, Mariano M, Hatzipetrou G, Bowman M, Morokuma J, Ortiz G, Hamrah P, Dartt DA, Zoukhri D. Role of the Phospholipase C Pathway and Calcium Mobilization in Oxytocin-Induced Contraction of Lacrimal Gland Myoepithelial Cells. Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):25.
   doi: 10.1167/iovs.62.14.25. PMID: 34812841; PMCID: PMC8626846.

5. McKay EC, Counts SE. Oxytocin Receptor Signaling in Vascular Function and Stroke. Front Neurosci. 2020 Sep 25;14:574499.
   doi: 10.3389/fnins.2020.574499. PMID: 33071746; PMCID: PMC7544744.

6. Mustoe A, Taylor JH, French JA. Oxytocin structure and function in New World monkeys: from pharmacology to behavior. Integr Zool. 2018 Nov;13(6):634-654.
   doi: 10.1111/1749-4877.12318. PMID: 29436774; PMCID: PMC6089668.

7. Park J, Heffern MC. Metal Modulation of Oxytocin Structure, Function, and Receptor Interactions. Eur J Inorg Chem. 2026 Apr 6:e202500462.
   doi: 10.1002/ejic.202500462. Epub ahead of print. PMID: 42100490; PMCID: PMC13148446.

8. Chatterjee O, Patil K, Sahu A, Gopalakrishnan L, Mol P, Advani J, Mukherjee S, Christopher R, Prasad TS. An overview of the oxytocin-oxytocin receptor signaling network. J Cell Commun Signal. 2016 Dec;10(4):355-360.
   doi: 10.1007/s12079-016-0353-7. Epub 2016 Sep 14. PMID: 27624619; PMCID: PMC5143325.

9. Baribeau DA, Anagnostou E. Oxytocin and vasopressin: linking pituitary neuropeptides and their receptors to social neurocircuits. Front Neurosci. 2015 Sep 24;9:335.
   doi: 10.3389/fnins.2015.00335. PMID: 26441508; PMCID: PMC4585313.